Prof. Erik Stroes, Amsterdam, The Netherlands, provided a brief introduction on the emerging role of Lipoprotein (a) (Lp(a)), a genetic risk factor leading to an increased risk for cardiovascular disease. The introduction was followed by discussion with the EPCCS board and council members representing primary care from multiple European countries.
Introduction: Lipoprotein (a) 00:12
Lp(a) effect: Dependent on 'global' risk 04:48
What do the guidelines say? 05:59
Summary: Lp(a) time to start measuring in primary care? 09:52
Audience discussion 10:08Prof. Erik Stroes, department of Vascular Medicine, AmsterdamUMC, The Netherlands
The EPCCS Annual Cardiovascular Summit is designed to provide a dynamic platform for exchange between specialists and primary care professionals from across Europe. By bringing together diverse clinical perspectives, the summit aims to translate high-level cardiovascular research into practical, actionable strategies for the primary care setting, ultimately improving patient outcomes across the continent.
